远程检查评估:人工耳蜗用户异步监测与分诊的临床工具
本研究为单中心前瞻性重复测量队列研究,纳入32名经验丰富的人工耳蜗用户(28名成人、4名儿童),评估Remote Check App的易用性、接受度、重测信度及与常规临床测试的一致性。结果显示87%受试者认为易用,自测听阈与言语识别在诊所与居家环境的重测差异无统计学意义,患者驱动的流式ATT阈值较临床医生自由场啭音阈值显著低6.7 dB。
要点
- Remote Check App让CI用户居家自测听力,临床医生可异步审阅结果辅助管理决策。
- 自测ATT与DTT在诊所与居家环境的重测差异无统计学意义(p>0.05)。
- 患者自测流式ATT阈值较临床医生自由场啭音阈值低6.7 dB(p<0.001)。
核心结论
- Remote Check是首个利用无线流式传输实现全面、简便且可靠居家自测听力功能的CI远程医疗评估工具。
- 异步获取测试结果可帮助临床医生监测和分诊患者,减少不必要的门诊就诊、患者出行时间及相关费用。
研究设计与样本
- 单中心、前瞻性、重复测量队列研究,纳入32名经验丰富的人工耳蜗用户(28名成人、4名儿童)。
主要发现
- 87%的受试者评价Remote Check易于使用。
- 自测ATT在诊所与居家环境的平均组重测分数差异为1.4 dB(SD=1.97),DTT为1.6 dB(SD=1.54),均无统计学意义(p>0.05)。
- 患者驱动DTT在流式与自由场条件下的平均组重测分数差异为1.8 dB(SD=2.02)。
- 患者自测流式ATT阈值较临床医生自由场啭音阈值显著低6.7 dB(SD=6.8)(p<0.001)。
- Remote Check的ATT阈值与基于声音处理器阈值声压级预测的阈值无显著差异。
临床怎么用
- 可利用Remote Check进行居家自测听力,异步审阅结果以监测和分诊CI用户。
- 远程监测可能减少不必要的门诊就诊、患者出行时间及相关费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A new Remote Check App permits remote self-testing of hearing function for Nucleus cochlear implant (CI) recipients and enables asynchronous review by their clinician to support patient-management decisions. OBJECTIVES: To evaluate the Remote Check App for: (1) ease of use; (2) overall acceptance of the test battery by CI recipient or their carer in the home setting; (3) test-retest reliability of audiological threshold and speech recognition measures via wireless streaming; and (4) to compare outcomes from patient-driven measures with conventional clinician-driven measurements of aided-hearing function. DESIGN: Single-site, prospective, repeated-measures cohort study with 32 experienced CI users (28 adults and 4 children). METHODS: Participants completed self-testing using the Remote Check app at home and in the clinic. Measures include audiological, objective and subjective tests. Self-administered speech recognition in noise, via the digit triplets test (DTT) and aided thresholds, via the aided threshold test (ATT) were reassessed in free-field and by clinicians following conventional clinical protocols. Results of ATT and DTT were compared across test conditions. Completion time and perceived ease of self-driven assessments were documented. Insights from subsequent real-world experience with Remote Check are summarized and compared to the study findings. RESULTS: Remote Check was rated as easy to use by the majority (87%) of subjects. Mean group test-retest score differences for self-administered testing within the clinic versus at-home environments were nonsignificant (p > 0.05): 1.4 dB (SD = 1.97) for ATT and 1.6 dB (SD = 1.54) for DTT. Mean group test-retest score difference for patient-driven DTT in streamed versus the free-field condition was 1.8 dB (SD = 2.02). Self-administered, streamed, ATT via Remote Check, resulted in significantly lower thresholds compared to clinician-driven warble-tone thresholds in the free-field by 6.7 dB (SD = 6.8) (p < 0.001). ATT thresholds via Remote Check were not significantly different from predicted thresholds based on the Threshold Sound Pressure Level of the sound processor. CONCLUSION: Remote Check is the first CI telehealth assessment tool that uses wireless streaming to enable comprehensive, easy and reliable self-testing of hearing function by the CI recipient or their carer, in the comfort of their home. Asynchronous access to test results can assist clinicians in monitoring and triaging individuals for appropriate patient-management based on their needs. Use of remote monitoring may also help to reduce the burden of unnecessary clinic visits on clinic resources, patient travel time and associated costs. Remote Check is an important step toward addressing the current growing need for asynchronous audiological telepractice to support long-term care of CI recipients.
引用
- Maruthurkkara S, Case S, Rottier R, et al. Evaluation of Remote Check: A Clinical Tool for Asynchronous Monitoring and Triage of Cochlear Implant Recipients. Ear Hear. 2022. PMID: 34320523. doi:10.1097/AUD.0000000000001106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。